Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2025-12-24 @ 1:37 PM
NCT ID:
NCT07047495
Eligibility Criteria:
Inclusion criteria for prostate patients:
* Unifocal infiltrating ductal breast carcinoma, non-special histotype
* clinical stage T1-T2,N0
* No contraindications to MRI, or metal joint prostheses from knee to shoulder included, or femoral stent.
* Patients aged \>18 years
* Good general condition (ECOG 0-2)
* Expected active treatment (crioablation or surgery or radiotherapy ).
Exclusion Criteria:
* Exclusion criteria for prostate patients:
* Nodule involvement and metastasis (cN1 and/or cM1)
* Concomitant inflammation of the intestine
* Significant systemic diseases or ongoing oral anticoagulant therapy
* Non-compliance of dose constraints in the treatment plan
* Previous invasive cancer, unless the patient has had no disease for at least 3 years
* Mental disorders that cannot ensure valid informed consent
Exclusion criteria for breast patients:
* Histology other than non-special histotype and non-epithelial tumors (sarcoma, lymphoma)
* Male sex
* High-risk mutation carrier patients
* Bilateral breast cancer
* synchronous distant metastases
* Neoadjuvant therapy
* autoimmune connective tissue diseases
* previous radiotherapy to the chest
* Mental disorders that cannot ensure valid informed consent
* No previous thoracic radiotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07047495
Study Brief:
Protocol Section:
NCT07047495